You are here: Industry Insights > Artificial Intelligence

News List

Clinical Research Organization's (CROs) using Artificial Intelligence (AI) tools in restructuring the clinical trials Shruti Talashi
April 11, 2024
Healthcare is embracing AI for better diagnosis, drug development, and patient care.
Drug Apocalypse of the Future: Artificial Intelligence Discovers New Antibiotics, Disrupting Traditional Innovations Big Cat of Medical Field
March 11, 2024
At present, the use of artificial intelligence to participate in the discovery and design of new drugs has become a hot track for new drug research and development.
World Health Organization Guidelines on Artificial Intelligence Muhammad Asim Niazi
March 05, 2024
Artificial intelligence is gaining momentum in many industries, where it helps businesses achieve various milestones.
Artificial Intelligence for Drug Development David Orchard-Webb
July 31, 2023
Artificial Intelligence (AI) is making a significant impact in the pharmaceutical industry, revolutionizing various aspects of drug discovery, development, and healthcare.
Artificial Intelligence and COVID-19 Vaccines Lin Zhang
May 31, 2021
In recent years, AI, in general, is becoming a popular tool in the pharmaceutical industry, not just in the case of COVID specifically.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Pharmacovigilance (PV) Lin Zhang
November 04, 2020
Artificial Intelligence (AI) is a fast emerging technology, dealing with the development and study of intelligent machines and software.
Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipeline WorldPharmaNews
December 02, 2021
Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer...
Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine prnasia
August 05, 2021
Insilico Medicine announced that its AI-powered drug discovery platform had delivered the preclinical candidate ("PCC") for kidney fibrosis.
Texas Cardiac Arrhythmia Institute leader participates in clinical trial for world's first artificial intelligence technology for complex cardiac arrhythmia procedures prnasia
July 23, 2021
The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led a clinical study to evaluate the world's first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures.